SAN DIEGO, June 18, 2026
Channel Robotics, a pioneering medical technology company developing a novel AI-enabled handheld endoscopic robotic platform, has announced the successful completion of a $2.5 million Seed+ financing round led by True Ventures, bringing the company’s total funding to $4.6 million. The investment represents a significant milestone for the emerging MedTech innovator as it advances a next-generation robotic solution designed to transform minimally invasive procedures. The newly secured capital will support product development, regulatory advancement, manufacturing preparation, and commercialization activities as Channel Robotics works toward introducing a more accessible and scalable approach to endoscopic robotics. The funding round follows the company’s earlier $2.1 million seed financing and reflects growing investor confidence in technologies capable of improving procedural precision while reducing barriers to adoption in healthcare settings worldwide.
AI-Enabled Platform Aims to Democratize Endoscopic Robotics
Channel Robotics is developing a first-of-its-kind handheld robotic platform that delivers robotic-level dexterity through existing flexible endoscopes. Unlike conventional robotic surgery systems that often require substantial capital investments, dedicated infrastructure, and specialized operating room configurations, the company’s technology is designed to integrate seamlessly into existing clinical workflows. The platform combines advanced robotic instrumentation, intuitive control systems, and artificial intelligence-driven capabilities to enhance physician control and precision during minimally invasive procedures.
By leveraging current endoscopic equipment already used in hospitals, ambulatory surgery centers, and community clinics, the technology has the potential to significantly broaden access to robotic-assisted interventions. The company believes this approach could accelerate adoption of robotic technologies across a wider range of healthcare environments while helping clinicians perform increasingly complex procedures with greater efficiency and accuracy.
Funding Supports Regulatory and Product Development Milestones
Advertisement
The newly announced financing will be directed toward several strategic objectives that are critical to the company’s future growth. Channel Robotics plans to continue refining and validating its prototype platform while expanding engineering and product development operations. Additional resources will be allocated to advancing manufacturing processes and establishing quality systems necessary to support future regulatory submissions. The company is currently targeting a U.S. Food and Drug Administration (FDA) submission in 2027, representing a major milestone in its pathway toward commercialization.
With support from investors including True Ventures, Defined Ventures, and Old Line Capital Partners, the company expects to accelerate development activities and strengthen its readiness for clinical adoption. Industry observers increasingly view robotic-assisted endoscopy as a rapidly growing segment within the broader medical robotics market, creating substantial opportunities for innovative solutions capable of improving accessibility and affordability.
Expanding the Future of Minimally Invasive Surgery
The latest investment highlights increasing momentum behind technologies that combine robotics, artificial intelligence, and minimally invasive surgical techniques. Channel Robotics was founded by physician-scientist Dr. Philip Weissbrod and roboticist Dr. Michael Yip, bringing together expertise in clinical medicine, engineering, and robotics innovation. Their vision is centered on creating practical robotic solutions capable of reaching significantly more physicians and patients than traditional robotic systems. As healthcare providers continue seeking technologies that improve procedural outcomes, reduce costs, and streamline workflows, demand for compact and adaptable robotic platforms is expected to grow rapidly.
By focusing on portability, affordability, and integration with existing endoscopic procedures, Channel Robotics is positioning itself at the forefront of a new category of endoscopic robotic technologies. The successful financing round provides the company with the resources needed to advance its platform toward commercialization and potentially reshape the future of minimally invasive care through broader access to advanced robotic capabilities.
Source: Channel Robotics press release
